A. Auriemma

1.1k total citations
27 papers, 469 citations indexed

About

A. Auriemma is a scholar working on Oncology, Epidemiology and Cancer Research. According to data from OpenAlex, A. Auriemma has authored 27 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 8 papers in Epidemiology and 6 papers in Cancer Research. Recurrent topics in A. Auriemma's work include Pancreatic and Hepatic Oncology Research (9 papers), Colorectal Cancer Treatments and Studies (8 papers) and Neuroendocrine Tumor Research Advances (4 papers). A. Auriemma is often cited by papers focused on Pancreatic and Hepatic Oncology Research (9 papers), Colorectal Cancer Treatments and Studies (8 papers) and Neuroendocrine Tumor Research Advances (4 papers). A. Auriemma collaborates with scholars based in Italy, United States and Austria. A. Auriemma's co-authors include Elena Fiorio, Eva Surmacz, Anna Mercanti, Annamaria Molino, Gian Luigi Cetto, Rocco Micciolo, Viviana Bartella, Sandra Cascio, Antonio Russo and Mirko D’Onofrio and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

A. Auriemma

25 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Auriemma Italy	11	331	128	117	107	80	27	469
Anna Mercanti Italy	7	159 0.5×	64 0.5×	117 1.0×	92 0.9×	46 0.6×	14	359
Philippe Berthelémy France	8	255 0.8×	98 0.8×	200 1.7×	67 0.6×	34 0.4×	12	412
İsmail Gömceli Türkiye	12	142 0.4×	73 0.6×	218 1.9×	253 2.4×	39 0.5×	36	613
Tına Mistry United Kingdom	6	106 0.3×	189 1.5×	58 0.5×	116 1.1×	82 1.0×	9	392
F. Castro e Sousa Portugal	11	175 0.5×	50 0.4×	156 1.3×	66 0.6×	32 0.4×	34	388
Maria Gebre‐Medhin Sweden	9	113 0.3×	36 0.3×	68 0.6×	51 0.5×	49 0.6×	18	371
Mao‐Min Song China	16	212 0.6×	34 0.3×	272 2.3×	69 0.6×	90 1.1×	31	529
Guang‐Yan Yu China	10	70 0.2×	57 0.4×	83 0.7×	89 0.8×	64 0.8×	32	353
Kazutoshi Tobimatsu Japan	10	243 0.7×	233 1.8×	64 0.5×	22 0.2×	54 0.7×	22	442
Steffen Spoerl Germany	11	106 0.3×	78 0.6×	102 0.9×	79 0.7×	150 1.9×	34	487

Countries citing papers authored by A. Auriemma

Since Specialization

Citations

This map shows the geographic impact of A. Auriemma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Auriemma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Auriemma more than expected).

Fields of papers citing papers by A. Auriemma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Auriemma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Auriemma. The network helps show where A. Auriemma may publish in the future.

Co-authorship network of co-authors of A. Auriemma

This figure shows the co-authorship network connecting the top 25 collaborators of A. Auriemma. A scholar is included among the top collaborators of A. Auriemma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Auriemma. A. Auriemma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dalbeni, Andrea, Filippo Cattazzo, Bernardo Stefanini, et al.. (2025). What can real-world data teach us about treating patients with unresectable hepatocellular carcinoma?. Expert Review of Gastroenterology & Hepatology. 19(4). 389–398.

Dalbeni, Andrea, Filippo Cattazzo, A. Auriemma, et al.. (2025). Glucagon‐Like Peptide‐1 Receptor Agonists and Hepatocellular Carcinoma Prevention: A Meta‐Analysis and Clinical Decision Framework. Cancer Medicine. 14(24). e71434–e71434.

Avancini, Alice, Ilaria Trestini, Daniela Tregnago, et al.. (2024). A Feasibility Study Investigating an Exercise Program in Metastatic Cancer Based on the Patient-Preferred Delivery Mode. The Oncologist. 29(6). e828–e836. 8 indexed citations

Dalbeni, Andrea, Filippo Cattazzo, Antonio Vella, et al.. (2023). Interleukin-6: A New Marker of Advanced-Sarcopenic HCC Cirrhotic Patients. Cancers. 15(9). 2406–2406. 10 indexed citations

Bordonaro, Roberto, Aitana Calvo, A. Auriemma, et al.. (2021). Trifluridine/tipiracil in combination with oxaliplatin and either bevacizumab or nivolumab in metastatic colorectal cancer: a dose-expansion, phase I study. ESMO Open. 6(5). 100270–100270. 11 indexed citations

Rossi, Gabriella, Salvatore Paiella, R Rossi, et al.. (2021). Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic Cancer. Frontiers in Oncology. 11. 662205–662205. 7 indexed citations

Trestini, Ilaria, Luisa Carbognin, Umberto Peretti, et al.. (2021). Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic Adenocarcinoma. Frontiers in Oncology. 11. 688889–688889. 14 indexed citations

Salvatore, Lisa, Maria Bensi, Salvatore Corallo, et al.. (2021). Phase II study of preoperative (PREOP) chemoradiotherapy (CTRT) plus avelumab (AVE) in patients (PTS) with locally advanced rectal cancer (LARC): The AVANA study.. Journal of Clinical Oncology. 39(15_suppl). 3511–3511. 42 indexed citations

Salvatore, Lisa, Maria Bensi, Filippo Pietrantonio, et al.. (2019). Phase II study of preoperative (PREOP) chemoradiotherapy (CTRT) plus avelumab (AVE) in patients (PTS) with locally advanced rectal cancer (LARC): The AVANA Study. Annals of Oncology. 30. v249–v249. 6 indexed citations

10.

Trestini, Ilaria, Luisa Carbognin, Isabella Sperduti, et al.. (2018). Prognostic impact of early nutritional support in patients affected by locally advanced and metastatic pancreatic ductal adenocarcinoma undergoing chemotherapy. European Journal of Clinical Nutrition. 72(5). 772–779. 28 indexed citations

11.

Trestini, Ilaria, Luisa Carbognin, Clelia Bonaiuto, et al.. (2017). Prognostic impact of nutritional support in patients affected by locally advanced or metastatic pancreatic cancer (PC) undergone chemotherapy. Annals of Oncology. 28. vi47–vi47. 1 indexed citations

12.

Calvetti, Lorenzo, Michele Pavarana, A. Auriemma, et al.. (2015). Effectiveness of Cetuximab (Cet) and Bevacizumab (Bev) for metastatic colorectal cancer (mCRC) according to primary tumor location (PTL): findings from a ‘real-world’ retrospective analysis. Annals of Oncology. 26. vi40–vi40. 3 indexed citations

13.

Cereda, Stefano, Michèle Milella, Stefano Cordio, et al.. (2015). Capecitabine with/without mitomycin C: results of a randomized phase II trial of second-line therapy in advanced biliary tract adenocarcinoma. Cancer Chemotherapy and Pharmacology. 77(1). 109–114. 12 indexed citations

14.

Vaccaro, Vanja, Emilio Bria, Isabella Sperduti, et al.. (2012). Optimizing supportive measures for the safe administration of FOLFIRINOX as first-line treatment in advanced, inoperable pancreatic cancer (aPDAC) patients (pts) in routine clinical practice.. Journal of Clinical Oncology. 30(15_suppl). e14661–e14661. 2 indexed citations

15.

Cantore, Maurizio, R. Girelli, Andrea Mambrini, et al.. (2012). Combined modality treatment for patients with locally advanced pancreatic adenocarcinoma. British journal of surgery. 99(8). 1083–1088. 52 indexed citations

16.

Butturini, Giovanni, Michele Pisano, Aldo Scarpa, et al.. (2010). Aggressive approach to acinar cell carcinoma of the pancreas: a single-institution experience and a literature review. Langenbeck s Archives of Surgery. 396(3). 363–369. 47 indexed citations

17.

Fiorio, Elena, Anna Mercanti, Marianna Terrasi, et al.. (2008). Leptin/HER2 crosstalk in breast cancer: in vitro study and preliminary in vivoanalysis. BMC Cancer. 8(1). 305–305. 94 indexed citations

18.

Bartella, Viviana, Sandra Cascio, Elena Fiorio, et al.. (2008). Insulin-Dependent Leptin Expression in Breast Cancer Cells. Cancer Research. 68(12). 4919–4927. 59 indexed citations

19.

Molino, Annamaria, Monica Giovannini, A. Auriemma, et al.. (2006). Pathological, biological and clinical characteristics, and surgical management, of elderly women with breast cancer. Critical Reviews in Oncology/Hematology. 59(3). 226–233. 49 indexed citations

20.

Orditura, Michele, Ferdinando De Vita, Berardo Sarubbi, et al.. (1998). Analysis of recovery time indexes in 5-fluorouracil-treated cancer patients.. Oncology Reports. 5(3). 645–7. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact